Blog
RSS FeedPosted by Michael Wonder on 26 Aug 2021
PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding
26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...
Posted by Michael Wonder on 22 Jun 2021
Proposal for the supply of primidone and gabapentin
22 June 2021 - PHARMAC is seeking additional feedback on a proposal to change the funded brands of primidone tablets ...
Posted by Michael Wonder on 01 Mar 2021
Proposal to fully fund Mercilon 28 for oral contraception
26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...
Posted by Michael Wonder on 04 Dec 2020
Proposal to widen access to rituximab for treatment of membranous nephropathy
4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...
Posted by Michael Wonder on 12 Nov 2020
Proposal to widen access to valganciclovir for transplant patients
12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...
Posted by Michael Wonder on 02 Oct 2020
Proposal to widen access to sirolimus for lymphovascular malformations and tuberous sclerosis complex complications
2 October 2020 - PHARMAC is seeking feedback on a proposal to widen funded access to sirolimus from 1 February ...
Posted by Michael Wonder on 18 Sep 2020
Proposal to fund emicizumab for people with haemophilia A
18 September 2020 - PHARMAC is seeking feedback on a proposal to fund emicizumab (Hemlibra), a new treatment for people with ...
Posted by Michael Wonder on 11 Aug 2020
Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule
11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...
Posted by Michael Wonder on 30 Jul 2020
Proposal to fund an additional brand of budesonide with eformoterol
30 July 2020 - PHARMAC is seeking feedback on a proposal to fund an additional brand (DuoResp Spiromax) of two ...
Posted by Michael Wonder on 02 Jul 2020
Modifying funded access to mifepristone and misoprostol
2 July 2020 - PHARMAC is pleased to announce a decision to: ...
Posted by Michael Wonder on 21 May 2020
Proposal to award sole supply of infliximab in DHB hospitals
21 May 2020 - PHARMAC is proposing to award sole supply of infliximab, a biologic medicine used to treat a ...
Posted by Michael Wonder on 02 Apr 2020
Proposal to fund modified release pancreatic enzyme granules (Creon Micro)
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
Posted by Michael Wonder on 24 Jan 2020
PHARMAC seeking views on new cystic fibrosis medicine
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...
Posted by Michael Wonder on 20 Jan 2020
Fees and charges proposal 2020-21
20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...
Posted by Michael Wonder on 15 Jan 2020
Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis
15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...